Introduction to Therapeutic Drug Monitoring. Frequently and Less Frequently Monitored Drugs

作者: Amitava Dasgupta

DOI: 10.1016/B978-0-12-385467-4.00001-4

关键词:

摘要: Therapeutic drug monitoring is useful for individual dosage adjustment and avoiding toxicity certain drugs with a narrow therapeutic window. However, only relatively few require most of these are used treating chronic condition. The exceptions vancomycin aminoglycosides, which short time life-threatening infection. These due to their high threshold toxicity. In general approximately 26 routinely monitored in clinical laboratories, there readily available immunoassays can be adopted on automated analyzers. include cardioactive drugs, anticonvulsants, anti-asthmatics, tricyclic antidepressants, immunosuppressants, antibiotics anticancer – commonly, methotrexate. There 25–30 that less frequently, not commercially available. Therefore, chromatographic methods usually employed determination serum, plasma or whole blood. newer anticonvulsants (such as lamotrigine gabapentin), (for example, flecainide, tocainide, etc.), several antidepressants the SSRI (selective serotonin reuptake inhibitor) class fluoxetine, paroxetine, sertraline).

参考文章(81)
Howanitz Pj, Steindel Sj, Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels. Archives of Pathology & Laboratory Medicine. ,vol. 117, pp. 684- 690 ,(1993)
Justin J. Anker, Marilyn E. Carroll, Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Current topics in behavioral neurosciences. ,vol. 8, pp. 73- 96 ,(2010) , 10.1007/7854_2010_93
M Mittelman, G Fink, J Gardyn, A Zeidman, Z Fradin, [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?]. Harefuah. ,vol. 133, pp. 3- 80 ,(1997)
Hema Padmanabhan, Amiodarone and thyroid dysfunction. Southern Medical Journal. ,vol. 103, pp. 922- 930 ,(2010) , 10.1097/SMJ.0B013E3181E90500
Jason A. Roberts, Ross Norris, David L. Paterson, Jennifer H. Martin, Therapeutic drug monitoring of antimicrobials British Journal of Clinical Pharmacology. ,vol. 73, pp. 27- 36 ,(2012) , 10.1111/J.1365-2125.2011.04080.X
Lucy S Hodge, Timothy S Tracy, Alterations in drug disposition during pregnancy Expert Opinion on Drug Metabolism & Toxicology. ,vol. 3, pp. 557- 571 ,(2007) , 10.1517/17425255.3.4.557
Offie P Soldin, Donald R Mattison, Sex Differences in Pharmacokinetics and Pharmacodynamics Annual Review of Pharmacology and Toxicology. ,vol. 44, pp. 499- 523 ,(2004) , 10.1146/ANNUREV.PHARMTOX.44.101802.121453
Uma Kotagal, Amadeo J. Pesce, Mitchell Rashkin, Standards of laboratory practice: theophylline and caffeine monitoring Clinical Chemistry. ,vol. 44, pp. 1124- 1128 ,(1998) , 10.1093/CLINCHEM/44.5.1124
Jia Wang, Huijuan Kou, Qiang Fu, Yang Han, Zhifeng Qiu, Lingyan Zuo, Yanling Li, Zhu Zhu, Min Ye, Qing Ma, Taisheng Li, Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection PLoS ONE. ,vol. 6, pp. e26739- ,(2011) , 10.1371/JOURNAL.PONE.0026739
Jason Lazarou, Bruce H. Pomeranz, Paul N. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA. ,vol. 279, pp. 1200- 1205 ,(1998) , 10.1001/JAMA.279.15.1200